Vol 62, No 4 (2005)
Other
Published online: 2005-12-12
Submitted: 2012-12-28
Get Citation

Clinical predictors of defibrillation threshold in patients with implantable cardioverter-defibrillators

Andrzej Lubiński, Ewa Lewicka-Nowak, Agnieszka Zienciuk, Tomasz Królak, Maciej Kempa, Anna Pazdyga, Grażyna Świątecka
Kardiol Pol 2005;62(4):323-328.
Vol 62, No 4 (2005)
Other
Published online: 2005-12-12
Submitted: 2012-12-28

Abstract

Background: Safety of patients with malignant ventricular arrhythmias, treated with implantable cardioverterdefibrillators (ICD), depends on the possibility of immediate and effective intracardiac defibrillation. It is especially important in those patients in whom there is a risk of increased defibrillation threshold (DFT) of ventricular fibrillation (VF). Thus, it is important to know whether some clinical parameters may predict a high DFT.
Aim: To assess the relationship between DFT and clinical, demographic and antropometric parameters, type and progression of underlying disease as well as antiarrhyhmic therapy used in ICD recipients.
Methods: The study group consisted of 168 patients (47 females, 121 males, mean age 55±15 years, range 15-82 years) who were selected to receive an ICD. DFT was systematically tested during ICD implantation in all patients. Various clinical, demographic, antropometric and echocardiographic parameters were analysed as the function of DFT value, examining their accuracy in predicting a high (≥15 J) or a low (

Abstract

Background: Safety of patients with malignant ventricular arrhythmias, treated with implantable cardioverterdefibrillators (ICD), depends on the possibility of immediate and effective intracardiac defibrillation. It is especially important in those patients in whom there is a risk of increased defibrillation threshold (DFT) of ventricular fibrillation (VF). Thus, it is important to know whether some clinical parameters may predict a high DFT.
Aim: To assess the relationship between DFT and clinical, demographic and antropometric parameters, type and progression of underlying disease as well as antiarrhyhmic therapy used in ICD recipients.
Methods: The study group consisted of 168 patients (47 females, 121 males, mean age 55±15 years, range 15-82 years) who were selected to receive an ICD. DFT was systematically tested during ICD implantation in all patients. Various clinical, demographic, antropometric and echocardiographic parameters were analysed as the function of DFT value, examining their accuracy in predicting a high (≥15 J) or a low (
Get Citation

Keywords

implantable cardioverter-defibrillator - defibrillation threshold

About this article
Title

Clinical predictors of defibrillation threshold in patients with implantable cardioverter-defibrillators

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Vol 62, No 4 (2005)

Pages

323-328

Published online

2005-12-12

Bibliographic record

Kardiol Pol 2005;62(4):323-328.

Keywords

implantable cardioverter-defibrillator - defibrillation threshold

Authors

Andrzej Lubiński
Ewa Lewicka-Nowak
Agnieszka Zienciuk
Tomasz Królak
Maciej Kempa
Anna Pazdyga
Grażyna Świątecka

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl